✦ LIBER ✦

Treatment of metastatic colorectal carcinoma with 5-fluorouracil by mouth

✍ Scribed by S. R. Lahiri; G. Boileau; T. C. Hall

Publisher: John Wiley and Sons
Year: 1971
Tongue: English
Weight: 993 KB
Volume: 28
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(1971)28:4<902::aid-cncr2820280413>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of 5-fluorouracil with 5-fluo

Comparison of 5-fluorouracil with 5-fluorouracil, cyclophosphamide, and methotrexate in metastatic colorectal carcinoma

✍ Frederick Richards II; Thomas L. Pajak; Miles R. Cooper; Charles L. Spurr 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

Thirty-eight patients with metastatic colorecal carcinoma were treated with 5-fluorouracil (5-FU), and 38 patients were treated with the combination of 5-FU, cyclophosphamide, and methotrexate. In terms of percent response, response duration, and survival there was no apparent difference between the

A dose-intensive regimen of 5-fluorourac

A dose-intensive regimen of 5-fluorouracil for the treatment of metastatic colorectal carcinoma

✍ Elizabeth A. Poplin; Michael Kraut; Laurence Baker; Joanne Brodfuehrer; Vainutis 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

A comprehensive review of 5-fluorouracil

A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma

✍ David Machover 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## Background: Colorectal carcinoma is the third leading cause of cancer-related death. the primary treatment for patients with metastatic colorectal carcinoma is systemic chemotherapy with 5-fluorouracil (5-fu) and leucovorin (lv), a biomodulator of 5-fu that has been shown to enhance its activity

Long-term ambulatory treatment of metast

Long-term ambulatory treatment of metastatic colorectal adenocarcinoma by continuous intravenous infusion of 5-fluorouracil

✍ E. Quebbeman; R. Ausman; R. Hansen; T. Becker; G. Caballero; P. Ritch; D. Jenkin 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

Prospective randomized reappraisal of 5-

Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma a comparative trial with 6-thioguanine

✍ Cary A. Presant; Alex E. Denes; Charlene Liu; Alfred A. Bartolucci; The Southeas 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

In order to redefine the effectiveness of 5-fluorouracil (5-FU) as palliative therapy in patients with metastatic colorectal carcinoma, and to compare the effectiveness of 6-thioguanine (6-TG) with that of 5-FU, we studied 176 patients with metastatic colorectal carcinoma in a randomized prospective

A multicenter evaluation of intensified,

A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma

✍ Francis Lévi; Rachid Zidani; Silvano Brienza; Luigi Dogliotti; Bruno Perpoint; M 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## BACKGROUND. The combination of 5-fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (l-OHP) was shown to be both more active against metastatic colorectal carcinoma and better tolerated if the drug delivery rate was chronomodulated according to circadian rhythms rather than constant. This all